| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |